Loading clinical trials...
Loading clinical trials...
Expanding an Active Surveillance Cohort to Improve Survivorship for Men With Favorable Risk Prostate Cancer
Conditions
Interventions
Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the prostate
Locations
2
United States
Northwestern University
Chicago, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Start Date
October 15, 2022
Primary Completion Date
June 30, 2026
Completion Date
December 31, 2026
Last Updated
April 15, 2026
NCT06594926
NCT06257264
NCT03620786
NCT04693377
NCT06190899
NCT02706561
Lead Sponsor
Northwestern University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions